Kathy D. Miller, MD
Kathy D. Miller, MD, is an associate professor and Sheila D. Ward Scholar at Indiana University. She is the author of more than 60 scientific papers, many of which focus on breast cancer biology and treatment.
Dr. Miller has a special interest in new cancer treatments, including clinical trials of biologically based therapies. She was a principal investigator for E2100, the first phase III clinical trial to confirm the benefits of anti-angiogenesis, a form of targeted therapy that stops tumors from making new blood vessels, in women with metastatic breast cancer.
Dr. Miller is a member of LBBC’s Medical Advisory Board and speaks frequently for many LBBC programs.
- Studies Reach Different Conclusions on Interaction of Antidepressants and Tamoxifen
- Trial Examines Optimal Treatments for HER2-Positive Early Breast Cancer
- What's New? Breaking News from the 31st Annual San Antonio Breast Cancer Symposium
- Possible New Treatment for Metastatic Breast Cancer
- Metastatic Breast Cancer Series: Guide for the Newly Diagnosed
- FDA Grants Accelerated Approval of Palbociclib